Skip to Content

PABAL 100 MICROGRAMS IN 1ML OF SOLUTION FOR INJECTION

Active substance: CARBETOCIN

View full screen / Print PDF » Download PDF ⇩
Transcript
= No print
area

= Folding
line

=Perforation

Pharmacode
70 mm
from top
and
centered
in box as
35 mm.
Drawring
E-MS-3063
Size
150x500mm



Maximum length of
pharmacode. 21 mm

Maximum length of
pharmacode. 21 mm



Fiber direction



Read all of this leaflet carefully before you are given an
injection of PABAL because it contains important
information for you.

If you get any side effects, tell your doctor, midwife
or nurse. This includes any possible side effects not listed
in this leaflet. See section 4.

What is in this leaflet
1.

What PABAL is and what it is used for

2.

What you need to know before you are treated with PABAL

3.

How PABAL is given to you

4.

Possible side effects

5.

How PABAL is stored

6.

Contents of the pack and other information

2 What you need to know before you are treated
with PABAL

Children: Not relevant
Other medicines and PABAL

2009052934

vial

If you get any side effects, talk to your doctor, medwife or nurse. This
includes any possible side effects not listed in this leaflet. You can also
report side effects directly (see below). By reporting side effects you can
help provide more information on the safety of this medicine.
United Kingdom: Yellow Card Scheme; Website: www.mhra.gov.uk/yellowcard
Ireland: HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2.
Tel: +353 1 6764971; Fax: +353 1 6762517;
Website: www.hpra.ie; E-mail: medsafety@hpra.ie
PABAL vials are stored in the outer carton in order to protect
from light. Store below 30 oC. Do not freeze.
PABAL must not be used after the expiry date printed on
the carton and vial.
PABAL should be kept out of sight and reach of children.

6. Contents of the pack and other information
The active substance is carbetocin. Each millilitre contains 100
micrograms of carbetocin. The other ingredients are L-methionine,
succinic acid, mannitol, sodium hydroxide, water for injections.
Pabal ia a clear colourless solution for injection, ready for
intravenous injection, supplied in packs of five vials of 1 ml.

PABAL / DURATOCIN / DURATOBAL

March 2015.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide